Bahamas vs Puerto Rico: The number of people with susceptibility test result for rifampicin
Bahamas
12
in 2021
Puerto Rico
14
in 2021
Bahamas rank
138th
Puerto Rico rank
136th
The number of people with susceptibility test result for rifampicin over time
- Bahamas
- Puerto Rico
How they compare
Puerto Rico currently reports 14 against 12 in Bahamas, a difference of 2.
That makes Puerto Rico's figure about 1.2 times Bahamas's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Puerto Rico ahead.
Bahamas ranks 138th and Puerto Rico ranks 136th of 155 countries.
Puerto Rico has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bahamas | Puerto Rico | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 17.67 | 25.33 | 7.67 | Puerto Rico |
| 2020s | 16 | 18 | 2 | Puerto Rico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bahamas or Puerto Rico?
- Puerto Rico, at 14 against 12 in Bahamas as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bahamas and Puerto Rico?
- 2, with Puerto Rico ahead.
- How many years of comparable data are there for Bahamas and Puerto Rico?
- 5 years are reported by both, from 2017 to 2021.
- How do Bahamas and Puerto Rico rank globally for the number of people with susceptibility test result for rifampicin?
- Bahamas ranks 138th and Puerto Rico ranks 136th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.